Skip to main content

Find Clinical Trials

Home
Conditions
Penetrating Keratoplasty

Clinical trial condition

Penetrating Keratoplasty

Explore clinical trials studying Penetrating Keratoplasty. Study availability and eligibility vary by location and protocol.

6 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Penetrating Keratoplasty trial results

Recruiting

Effectiveness of PKP vs DSAEK in Terms of 2-year Postoperative Visual Acuity in Advanced BPK

NCT06818747

Conditions: Bullous Pseudophakic Keratopathy, Penetrating Keratoplasty
Locations: CHU Besançon - Hôpital Jean Minjoz Besançon, France

CHU Bordeaux - Hopital Pellegrin Bordeaux, France

CHU Brest - Hopital Morvan Brest, France

CHR Metz-Thionville Hopital de Mercy Metz, France

View Trial Details

Not Yet Recruiting

Subconjunctival Humira for Boston Keratoprosthesis

NCT06926478

Conditions: Chemically-Induced Disorders, Conjunctival Diseases, Dermatitis, +20 more
Locations: Massachusetts Eye and Ear Boston, Massachusetts, United States

View Trial Details

Completed

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery

NCT04521140

Conditions: Anterior Chamber Inflammation, Corneal Defect, Corneal Diseases, +12 more
Locations: Advanced Vision Care Los Angeles, California, United States

View Trial Details

Completed

A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery

NCT04975971

Conditions: Anterior Chamber Inflammation, Cataract Senile, Corneal Defect, +13 more
Locations: Advanced Vision Care Los Angeles, California, United States

View Trial Details

Completed

Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries

NCT01075347

Conditions: Cardiovascular Diseases, Corneal Epithelial Defect, Diabetes Complications, +8 more
Locations: National Taiwan University Hospital, department of Ophthalmology Taipei, Taiwan

View Trial Details

Completed

Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization

NCT00681603

Conditions: Corneal Diseases, Corneal Neovascularization, Eye Diseases, +10 more
Locations: Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan

View Trial Details